文献速递临床试验与 GCP

50-65岁肱骨近端骨折手术与非手术治疗比较:Young Shoulder CARE(移位的肱骨近端骨折)试验——一项实用性随机对照试验研究方案

Surgical versus non‑surgical treatment of proximal humerus fracture in patients aged 50-65 years: young shoulder CARE (displaCed proximAl humeRus fracturE) trial-a pragmatic randomized controlled trial study protocol.
PubMed 文献 · Trials · 2025-12-29

本研究为多中心、平行组、随机、优效性试验,拟纳入60例50-65岁移位肱骨近端骨折患者,等比例随机接受手术(主要行内固定)或非手术治疗,主要结局为12个月时牛津肩关节评分(OSS)的组间差异。样本量按OSS临床相关差异9.6分(标准差12)、80%把握度、5%显著性水平计算。

要点

  • 50-65岁移位肱骨近端骨折患者手术与非手术治疗孰优缺乏证据。
  • 主要结局为12个月时牛津肩关节评分(OSS)的组间差异。
  • 治疗失败(持续疼痛或内固定失败)时提供挽救性手术。

核心结论

  • Young Shoulder CARE试验旨在为50-65岁移位肱骨近端骨折患者的治疗提供见解,并了解手术与非手术治疗方案的获益与危害。
  • 试验结果将在开放获取的同行评议期刊上发表。

研究设计与样本

  • 多中心、平行组、随机、优效性试验,比较内固定与非手术治疗50-65岁移位肱骨近端骨折患者。
  • 共60例患者将等比例随机分配至手术治疗(主要行内固定)或非手术治疗。
  • 所有患者在6周和6个月安排随访,手术组额外必须进行12周随访,非手术组12周随访为可选。
  • 样本量按牛津肩关节评分(OSS)临床相关差异9.6分(标准差12)、80%把握度、5%显著性水平计算。
  • 不同意随机的患者将被邀请参加非随机队列,记录基线和偏好数据,接受相同的随访和结局评估。

关键数值与推荐

  • 主要结局为12个月时牛津肩关节评分(OSS)的组间差异。
  • 样本量计算假设OSS临床相关差异为9.6分(标准差12),对应80%把握度和5%显著性水平。
  • 治疗失败(持续疼痛或内固定失败)时,将提供挽救性手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proximal humerus fractures (PHF) are common in adults above 50 years, often following low-energy trauma and underlying osteoporosis. Randomized trials in patients 60 years and older have found no clinically important difference in 1- and 2-year outcomes between surgical and non-surgical treatments. There is limited evidence for the 50-65 age group, who may have different functional demands and even a different overall health status. There is limited knowledge to guide treatment decisions for this age group. METHOD: A multicenter, parallel-group, randomized, superiority trial comparing osteosynthesis with non-surgical treatment in patients aged 50-65 years with displaced PHF. A total of 60 patients will be randomized equally to surgical treatment (primary osteosynthesis) or non-surgical treatment. Follow-up visits are arranged at 6 weeks and 6 months for all patients, with an additional 12-week visit mandatory for the surgical group and optional for the non-surgical group. The primary outcome is the between-group difference in Oxford Shoulder Score at 12 months. Sample size was calculated assuming a clinically relevant difference of 9.6 points on the OSS (SD 12), corresponding to 80% power at a 5% significance level. In case of treatment failure (persistent pain or a failed osteosynthesis), a salvage procedure will be offered. Patients not consenting to randomization will be asked to participate in a non-randomized cohort. They will have baseline data and preferences recorded, and they will receive the same follow-up and outcome assessments. DISCUSSION: Young shoulder CARE trial aims to provide insights into the treatment of displaced proximal humerus fractures in patients aged 50-65 years, and to understand the benefits and harms of both surgical and non-surgical treatment options. The trial results will be published in an open-access peer-reviewed journal. TRIAL REGISTRATION: Clinicaltrials.gov, NCT06416618, registered 14 May 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Houkjær L, Launonen AP, Sumrein BO, et al. Surgical versus non‑surgical treatment of proximal humerus fracture in patients aged 50-65 years: young shoulder CARE (displaCed proximAl humeRus fracturE) trial-a pragmatic randomized controlled trial study protocol. Trials. 2025. PMID: 41466383. doi:10.1186/s13063-025-09283-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。